Steve Elms, Director at ADMA BIOLOGICS, INC. (ADMA), sold 923,432 shares at $6.08 ($5.6M) on 2024-03-19, disclosed to the SEC on 2024-03-19.
Open-market sale of $5.6M ADMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.01 | 49,887 | $300K | 5.3% |
| 2 | $6.01 | 49,887 | $300K | 5.3% |
| 3 | $6.08 | 411,829 | $2.5M | 44.7% |
| 4 | $6.08 | 411,829 | $2.5M | 44.7% |
| Total | $6.07 avg | 923,432 | $5.6M | 100% |
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |
| MRKR | BUY | 2021-03-18 | $4.0M | — | Filing → |